Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson's Disease

Area of Science:

• Neuroscience
• Biomarker Discovery
• Quantitative Electroencephalography (qEEG)

Background:

• Cognitive decline is a significant issue in Parkinson's disease (PD).
• Quantitative electroencephalography (qEEG) is explored as a potential biomarker for cognitive impairment in PD.
• Existing methods may not be optimized for routine clinical application.

Purpose of the Study:

• To evaluate the utility of a wavelet-based qEEG algorithm for predicting cognitive impairment in PD.
• To assess if standard, resting-state EEG recordings from a clinical setting can be used.
• To identify specific qEEG features associated with cognitive status in PD.

Main Methods:

• Utilized a wavelet-transform based time-frequency algorithm on 21-electrode resting-state EEG recordings.
• Assessed instantaneous predominant frequency (IPF) and relative time spent in standard EEG bands (RTF) at each scalp location.
• Compared qEEG metrics between healthy controls, PD patients with normal cognition (PDN), and PD patients with impaired cognition (PDD).

Main Results:

• PD subjects showed altered RTF values compared to controls, with increased RTF-Theta and decreased RTF-Beta.
• Logistic regression and principal component analysis (PCA) revealed that specific combinations of RTF values could discriminate between PD and controls (AUC = 0.780).
• A distinct PCA component derived from RTF values in PD subjects significantly predicted cognitive status (AUC = 0.89), with higher RTF-Theta associated with impairment.

Conclusions:

• A wavelet-based qEEG algorithm applied to routine EEG recordings shows potential as a biomarker for PD.
• This method demonstrates utility in predicting cognitive impairment within the PD population.
• The findings suggest qEEG analysis can be a valuable tool in clinical practice for managing PD cognitive decline.